Discover more insights into Secondary Progressive

Keywords frequently search together with Secondary Progressive

Narrow sentence examples with built-in keyword filters

Secondary Progressive sentence examples within clinically isolated syndrome



Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes.



Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging.


Secondary Progressive sentence examples within relapsing remitting multiple



The cerebellum and its network: Disrupted static and dynamic functional connectivity patterns and cognitive impairment in multiple sclerosis.



Differing Impact of Disease-Modifying Therapy on Relapse and Progression


Secondary Progressive sentence examples within disability status scale



4CPS-333 Treating multiple sclerosis patients with infusion of disease modifying treatments during the COVID-19 pandemic



Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study



Learn more from Secondary Progressive


Secondary Progressive sentence examples within patients relapsing remitting



Severely disabled multiple sclerosis patients can achieve the performance of healthy subjects after expiratory muscle strength training.



Association study of rs7799039, rs1137101 and rs8192678 gene variants with disease susceptibility/severity and corresponding LEP, LEPR and PGC1A gene expression in multiple sclerosis.


Secondary Progressive sentence examples within 60 year old



Self-efficacy training as an adjunct to exercise in a person with progressive multiple sclerosis: a case report.



Transcranial Magnetic Stimulation (TMS) Improvement in Depression, Insomnia, and Fatigue Associated with Multiple Sclerosis (MS)


Secondary Progressive sentence examples within randomized controlled trial



Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis



Siponimod and Cognition in Secondary Progressive Multiple Sclerosis


Secondary Progressive sentence examples within min supine resting



Autonomic nervous system abnormalities predict cardiovascular changes after initiation of siponimod in secondary progressive multiple sclerosis


Secondary Progressive sentence examples within Active Secondary Progressive



Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis



Cyclophosphamide treatment in active multiple sclerosis


Secondary Progressive sentence examples within 16 Secondary Progressive



Retinal Nerve Fiber Layer Thickness Correlates with Serum and Cerebrospinal Fluid Neurofilament Levels and is Associated with Current Disability in Multiple Sclerosis.



Diffusion basis spectrum imaging provides insights into MS pathology


Secondary Progressive sentence examples within 26 Secondary Progressive



The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI



Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression.


Secondary Progressive sentence examples within Relapsing Secondary Progressive



Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial



Real-world experience of ocrelizumab initiation in a diverse multiple sclerosis population.


Secondary Progressive sentence examples within secondary progressive m



Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate



Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?


Secondary Progressive sentence examples within secondary progressive multiple



[Controversies in neurology: Diagnosis, follow up and therapy of multiple sclerosis with pathomechanismal approach].



Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.


Secondary Progressive sentence examples within secondary progressive disease



What Guides Peripheral Immune Cells into the Central Nervous System?



Epilepsy as a predictor of disease progression in multiple sclerosis.


Secondary Progressive sentence examples within secondary progressive phase



Remyelination and neuroprotective effects of alemtuzumab therapy in patients with multiple sclerosis



Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation


Secondary Progressive sentence examples within secondary progressive course



The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis



The study of the efficiency of robotic mechanotherapy with the use of an exoskeleton for the lower extremities in patients with multiple sclerosis with impaired walking function


Secondary Progressive sentence examples within secondary progressive patient



IMPACT OF RELAPSING REMITTING MULTIPLE SCLEROSIS ON COGNITIVE FUNCTION AND SLEEP PROFILE IN PATIENTS AT ALEXANDRIA UNIVERSITY HOSPITALS



Italian translation and psychometric validation of the ABILHAND-26 and its correlation with upper limb objective and subjective measures in multiple sclerosis subjects.



Subcortical lesions in various phenotypes of multiple sclerosis and their prognostic significance



Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate



Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation



[Controversies in neurology: Diagnosis, follow up and therapy of multiple sclerosis with pathomechanismal approach].



Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?


More Secondary Progressive sentence examples
10.1016/j.msard.2021.102778

Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.


More Secondary Progressive sentence examples
10.1212/WNL.0000000000011312

Ibudilast



When does a heap become a heap?



Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review



Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis


More Secondary Progressive sentence examples
10.3390/diagnostics11040686

The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study


More Secondary Progressive sentence examples
10.17116/jnevro2021121071124

[Siponimod: a new view at the therapy of secondary progressive multiple sclerosis].



Protective effect of the sphingosine-1 phosphate receptor agonist siponimodon disrupted blood brain barrier function.


More Secondary Progressive sentence examples
10.1212/NXI.0000000000001006

Network Damage Predicts Clinical Worsening in Multiple Sclerosis



[MSProDiscuss - Development of a digital anamnesis tool to identify disease progression in multiple sclerosis].


More Secondary Progressive sentence examples
10.1080/03007995.2021.1904860

Secondary progressive multiple sclerosis: a systematic review of costs and health state utilities



The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients



Perceptions of fatigue and fatigue management interventions among people with multiple sclerosis: a systematic literature review and narrative synthesis


More Secondary Progressive sentence examples
10.1016/j.msard.2021.102964

Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: A new mimicker of progressive multiple sclerosis?



Vitamin D Levels and Visual System Measurements in Progressive Multiple Sclerosis: A Cross-sectional Study.



Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology



Lateral Suboccipital Approach in Semisitting Position for Resection of Vagal Schwannoma: 2-Dimensional Operative Video.



Clinical and radiological activity of secondary progressive multiple sclerosis in a population‐based cohort



Reduction in Fatigue Symptoms Following the Administration of Nutritional Supplements in Patients with Multiple Sclerosis


More Secondary Progressive sentence examples
10.2174/1871527320666210129121701

Comparison of Pharmaceutical Effect of Alemtuzumab and Natalizumab and Their Side Effects in Treatment of Various Stages of Multiple Sclerosis Patients.


More Secondary Progressive sentence examples
10.1212/WNL.0000000000011314

Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study


More Secondary Progressive sentence examples
10.14412/2074-2711-2021-1-138-144

New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis



The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis


More Secondary Progressive sentence examples
10.1016/j.msard.2021.103172

A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington.



Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes


More Secondary Progressive sentence examples
10.1016/j.msard.2021.102973

Social cognition in multiple sclerosis and its subtypes: A meta-analysis.



Severe lymphopenia switching from Fingolimod to Siponimod



Involvement of cytotoxic Eomes-expressing CD4+ T cells in secondary progressive multiple sclerosis



Delayed amantadine toxicity causing apparent progression of multiple sclerosis.



Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study.



Retinal Thickness Analysis in Progressive Multiple Sclerosis Patients Treated With Epigallocatechin Gallate: Optical Coherence Tomography Results From the SUPREMES Study



827 Central Sleep Apnea in a patient with Multiple Sclerosis



Modeling the Cost-Utility of Treatment Sequences for Multiple Sclerosis


More Secondary Progressive sentence examples
10.1016/j.msard.2021.103185

Liver kinase B1 rs9282860 polymorphism and risk for multiple sclerosis in White and Black Americans.



The levels of the serine protease HTRA1 in cerebrospinal fluid correlate with progression and disability in multiple sclerosis



Sleep disorders in patients with multiple sclerosis in Spain.



IgGs-Abzymes from the Sera of Patients with Multiple Sclerosis Recognize and Hydrolyze miRNAs



Confirmed disability progression provides limited predictive information regarding future disease progression in multiple sclerosis



Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey.



The Effectiveness of Statins as Potential Therapy for Multiple Sclerosis: A Systematic Review of Randomized Controlled trials



Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients



Diffusely abnormal white matter converts to T2 lesion volume in the absence of acute inflammation



Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis



The First Cure Experience of A Clinic: Approach to The Patient to Start Ocrelizumab.



Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study


More Secondary Progressive sentence examples
10.1016/j.msard.2021.103086

Review of Phase III Clinical Trials Outcomes in Patients with Secondary Progressive Multiple Sclerosis.



Slowly expanding lesions are a marker of progressive MS – Yes


More Secondary Progressive sentence examples
10.1016/j.ebiom.2021.103590

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study



Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study



Ocrelizumab treatment in Multiple Sclerosis: A Danish population-based cohort study.


More Secondary Progressive sentence examples
10.1212/NXI.0000000000000975

Anti-CD20 Disrupts Meningeal B-Cell Aggregates in a Model of Secondary Progressive Multiple Sclerosis



MicroRNAs, Multiple Sclerosis, and Depression



Re-examining the effects of high-dose intravenous methylprednisolone for secondary progressive multiple sclerosis.


More Secondary Progressive sentence examples
10.1212/WNL.0000000000012510

Comparing the Effectiveness of Therapies in People With Secondary Progressive Multiple Sclerosis


More Secondary Progressive sentence examples
10.1080/03007995.2021.1968362

Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses.



Leukocyte Telomere Length in Patients with Multiple Sclerosis and Its Association with Clinical Phenotypes


More Secondary Progressive sentence examples
10.1016/j.msard.2021.103135

Vascular endothelial dysfunction associated with severity in multiple sclerosis.



WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumors


More Secondary Progressive sentence examples
10.17116/jnevro202112107213

[Rehabilitation of patients with multiple sclerosis].


More Secondary Progressive sentence examples
10.21608/alexpo.2021.87375.1227

IMPACT OF RELAPSING REMITTING MULTIPLE SCLEROSIS ON COGNITIVE FUNCTION AND SLEEP PROFILE IN PATIENTS AT ALEXANDRIA UNIVERSITY HOSPITALS


More Secondary Progressive sentence examples
10.1016/j.msard.2021.103281

Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany - A registry-based/multicentric cohort study.



Secondary Progressive
Encyclopedia